Phase II trial of mitoguazone in patients with refractory germ cell tumors.
Chun
H
H
Bosl
G J
GJ
D004341:Drug Evaluation; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy*; D008935:Mitoguazone / Q000009:adverse effects / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D011379:Prognosis; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D006146:Guanidines; D008935:Mitoguazone